Ghent University Academic Bibliography

Your filters: cql: author="Worm, Margitta" or (type any "bookEditor issueEditor" and editor="Worm, Margitta")

Add to list
- Journal Article
- A1
- open access
Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Marek Lommatzsch, Katharina Blumchen, Lisa A. Beck, Jean Bousquet, Guy Brusselle (UGent) , Wytske J. Fokkens, Eckard Hamelmann, Susanne Lau, Hagen Ott, Oliver Pfaar, et al.

(2025) ECLINICALMEDICINE. 80.
Add to list
- Journal Article
- A1
- open access
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

Oliver Pfaar, Frédéric De Blay, Giorgio Walter Canonica, Thomas B. Casale, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Giovanni Passalacqua, Miguel Tortajada-Girbés, Carmen Vidal, et al.

(2024) WORLD ALLERGY ORGANIZATION JOURNAL. 17(1).
Add to list
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly, Jonathan Corren, Peter Creticos, Frederic De Blay, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(3). p.1020-1030.e10
Add to list
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model

Cristoforo Incorvaia, Mona Al-Ahmad, Ignacio J. Ansotegui, Stefania Arasi, Claus Bachert (UGent) , Catherine Bos, Jean Bousquet, Andrzej Bozek, Davide Caimmi, Moises A. Calderon, et al.

(2021) ALLERGY. 76(4). p.1041-1052
Add to list
- Journal Article
- A1
- open access
Management of anaphylaxis due to COVID‐19 vaccines in the elderly

Jean Bousquet, Ioana Agache, Hubert Blain, Marek Jutel, Maria Teresa Ventura, Margitta Worm, Stefano Del Giacco, Athanasios Benetos, Maria Beatrice Bilo, Wienczyslawa Czarlewski, et al.

(2021) ALLERGY. 76(10). p.2952-2964
Add to list
- Miscellaneous
Glukokortikoide und Covid-19

Ludger Klimek, Ulrike Förster-Ruhrmann, Sven Becker, Adam Chaker, Tilman Huppertz, Thomas Deitmer, Heidi Olze, Sebastian Strieth, Margitta Worm, Eckard Hamelmann, et al.

(2020) ALLERGO JOURNAL. 29(3). p.58-59
Add to list
The role of mobile health technologies in allergy care : an EAACI position paper

Paolo Maria Matricardi, Stephanie Dramburg, Alberto Alvarez-Perea, Dario Antolin-Amerigo, Christian Apfelbacher, Marina Atanaskovic-Markovic, Uwe Berger, Michael S. Blaiss, Simon Blank, Elisa Boni, et al.

(2020) ALLERGY. 75(2). p.259-272
Add to list
- Journal Article
- A1
- open access
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32

Verena Niederberger, Angela Neubauer, Philippe Gevaert (UGent) , Mihaela Zidarn, Margitta Worm, Werner Aberer, Hans Jørgen Malling, Oliver Pfaar, Ludger Klimek, Wolfgang Pfützner, et al.

(2018) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 142(2). p.497-509
Add to list
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

Oliver Pfaar, Claus Bachert (UGent) , Albrecht Bufe, Roland Buhl, Christof Ebner, Peter Eng, Frank Friedrichs, Thomas Fuchs, Eckard Hamelmann, Doris Hartwig-Bade, et al.

(2014) ALLERGO JOURNAL INTERNATIONAL. 23(8). p.282-319

Academic Bibliography

Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model

Management of anaphylaxis due to COVID‐19 vaccines in the elderly

Glukokortikoide und Covid-19

The role of mobile health technologies in allergy care : an EAACI position paper

Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

Contents

Support

Contact